Irinotecan/cisplatin versus vindesine/cisplatin versus irinotecan alone in advanced non-small-cell lung cancer. (Record no. 14430894)

MARC details
000 -LEADER
fixed length control field 00731 a2200193 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514164817.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200401s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1525-7304
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.3816/clc.2001.n.001
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Fisher, M D
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20040123
245 00 - TITLE STATEMENT
Title Irinotecan/cisplatin versus vindesine/cisplatin versus irinotecan alone in advanced non-small-cell lung cancer.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical lung cancer
Date of publication, distribution, etc. Feb 2001
300 ## - PHYSICAL DESCRIPTION
Extent 180-1 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
773 0# - HOST ITEM ENTRY
Title Clinical lung cancer
Related parts vol. 2
-- no. 3
-- p. 180-1
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.3816/clc.2001.n.001">https://doi.org/10.3816/clc.2001.n.001</a>
Public note Available from publisher's website

No items available.